ISSN: 2165-7831

Journal of Blood & Lymph
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year
across USA, Europe & Asia with support from 1000 more scientific Societies and
Publishes 700+ Open Access Journals which contains over 50000
eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers
Each Journal is getting 25,000+ Readers
This Readership is 10 times more when compared to other
Subscription Journals (Source: Google Analytics)
 
 
 
 
 
 

Editorial Board

Guido J.K. Tricot

Editor-in-Chief
Guido J.K. Tricot
Professor
Department of Medicine
University of Utah
School of Medicine
USA

Biography :

Guido Tricot, MD, PhD, is the director of Huntsman Cancer Institutes Myeloma Program. He has been researching and treating multiple myeloma for over twenty years. Tricot is also a professor in the Department of Medicine at the University of Utah School of Medicine. His team treatment strategies are based on tandem autologous transplantation, a treatment approach that has increased the median survival rate of patients to ten years or more, compared to 2.5 to 3 years with conventional chemotherapy. The long-term outcome data of Dr. Tricots work have been published extensively. He has received several research grants from the National Cancer Institute and has been principal investigator on many myeloma clinical trials. Dr. Tricot regularly gives presentations on multiple myeloma all over the United States and the world. His research has appeared in numerous publications, including New England Journal of Medicine, the Lancet, the Journal of Clinical Oncology, Blood, Cancer Research, Clinical Cancer Research, the British Journal of Haematology, Seminars in Hematology, and Hematology/Oncology Clinics of North America. He is also a peer reviewer for many medical journals. He received his medical and doctoral degree at the University of Leuven in Belgium. Before joining Huntsman Cancer Institute, he was the Director of Clinical Research at the University of Arkansas Myeloma Institute for Research and Therapy, the largest myeloma program in the world. Dr. Tricot has also served as Director of Bone Marrow and Stem Cell Transplantation at the Greenebaum Cancer Center at the University of Maryland and at Indiana University.

 Biography
Research Interest :

His research has appeared in numerous publications, including New England Journal of Medicine, the Lancet, the Journal of Clinical Oncology, Blood, Cancer Research, Clinical Cancer Research, the British Journal of Haematology, Seminars in Hematology, and Hematology/Oncology Clinics of North America. He is also a peer reviewer for many medical journals.

 Research Interest
 Network
Susumu Ikehara

Executive Editor
Susumu Ikehara
Professor
Department of Stem Cell Disorders
Kansai Medical University
Japan
 

Biography :

Professor Susumu Ikehara received his M.D. in (1968) and his Ph.D. in 1977 degree (1977) from Kyoto University. He began his career in the Department of Pathology at Kyoto University in (1976), and was promoted to Professor of Pathology at Kansai Medical University (in 1986). He has served as Director of the Transplantation Center at Kansai Medical University since 1998, as well as Director of the Regeneration Research Center for Intractable Diseases since 2001, and finally as the Director for Cancer Therapy in since 2003 at Kansai Medical University. He has been a distinguished visiting investigator with Dr. Robert Good at Memorial Sloan Kettering Cancer Center in between 1978- and1981. Dr. Ikehara has received numerous awards.

 Biography
Research Interest :

Dr. Susuma Ikehara research interest lies in Bone marrow transplantation in autoimmunity and as well as in Pathology, Immunology, Hematology, Oncology, and Cancer.

 Research Interest
 Network
Joseph Rosenthal

Joseph Rosenthal
Chair
Department of Pediatrics
City of Hope National Medical Center
USA

Biography :

The proposed study will investigate new treatment modalities in the field of hematopoietic stem cell transplantation. I have a vast experience in cellular therapy, in its unrefined mode of hematopoietic stem cell transplantation, as well as in more selective cell therapeutics, such as CD34+ haploidentical transplant and CD8+ modified T cells in treatment of neuroblastoma, and most recently, in the early development phases of a study investigating modification of central memory derived CD19-specific T-cell grafts in patients with childhood CD19+ ALL. In my role as the director of a pediatric BMT unit, I have the expertise, leadership and motivation necessary to successfully carry out this project. As a board certified pediatric hematologist/oncologist I have a broad exposure to pre-B cell ALL, the most common cancer diagnosis in childhood. I have served as the PI on multiple clinical trials involving all sources of hematopoietic stem cells. Currently, I am the PI on trials involving cord blood transplants, haploidentical transplants, and clinical trials utilizing novel devices employed in conditioning therapy.In my role as PI it is my responsibility to oversee the administration of the projects, including and not limited to:staffing, research protections, budget, collaboration with other investigators, and publication of; peer-reviewed manuscripts from each project.As a result of these previous experiences, I am aware of the importance of frequent communication among project members and of constructing a realistic research plan, timeline, and budget.The current application builds on my prior work, as a clinical investigator.I have a demonstrated track record of successful and productive research projects in the area of cellular therapy. I am confident that my experience has prepared me to lead the proposed project.

 Biography
Research Interest :

Dr. Joseph Rosenthal research interest is New treatment modalities in the field of hematopoietic stem cell transplantation.

 Research Interest
 Network
Chao-Nan (Miles) Qian

Chao-Nan (Miles) Qian
Professor
Department of Nasopharyngeal Carcinoma
Laboratory of Cancer and Developmental Cell Biology
Van Andel Research Institute
USA

Biography :

Dr. Chao-Nan (Miles) Qian obtained his Bachelor in Medicine (equivalent to MD in the US) and PhD at Sun Yat-sen University of Medical Sciences, P. R. China in 1992 and 1999, respectively. His postdoctoral training was at University of Texas MD Anderson Cancer Center and Van Andel Research Institute in Michigan. He was appointed as Deputy Director of the Laboratory of Translational Cancer Research at National Cancer Center Singapore in May 2007. He then rejoined the Department of Nasopharyngeal Carcinoma at Sun Yat-sen University Cancer Center as a Professor in June 2007, and Assistant Director to the Cancer Center in January 2008. He has published more than 60 articles in peer-reviewed scientific journals, and an ad hoc journal reviewer for 18 scientific journals. Dr. Qian’s major research interests are molecular mechanisms of tumor metastasis, cellular and molecular mechanism of tumor angiogenesis and lymphangiogenesis, and molecular mechanisms of drug resistance in cancer cells.

 Biography
Research Interest :

Dr. Qian’s major research interests are molecular mechanisms of tumor metastasis, cellular and molecular mechanism of tumor angiogenesis and lymphangiogenesis, and molecular mechanisms of drug resistance in cancer cells.

 Research Interest
 Network
Ramzi M. Mohammad

Ramzi M. Mohammad
Professor
Department of Oncology
Wayne State University
USA
 

Biography :

Dr.Mohammad has more than 25 years of cancer research experience and publications exceeding 114 in peer reviewed journals and book chapters. Dr. Mohammad has extensive experience in physiology, cancer biology, animal models, tissue culture and statistical analysis. He has established a number of lymphoma and leukemia cell lines and xenograft models, in which he has years of experience in studying the effects of new anticancer agents, marine products as well as standard chemotherapeutic drugs.

 Biography
Research Interest :

Dr.Mohammad′s research is translational in nature and through his close work with clinicians he was able to introduce several experimental drugs into the clinic among which include Bryostatin-1, Aurastatin-PE, Dolastatin-10 and CA-4 (cambertastatin-4) and other small molecule inhibitors of Bcl-2 such as AT-101 (gossypol) and HMD2. Dr. Mohammad works in close association with GI cancer physicians at Karmanos Cancer Institute and has assisted many clinical trials.

 Research Interest
 Network
Arun K. Rishi

Arun K. Rishi
Professor
Department of Oncology and Internal Medicine
Wayne State University
USA
 

Biography :

Dr. Arun K. Rishi was born in Meerut, India. After the initial college education in India, Dr. Rishi obtained a M.Sc. in Biochemistry from University College London, UK, and a Ph.D. in Molecular Biology from Imperial College of Science Technology and Medicine, London, UK. He subsequently trained as a post-doctoral fellow at MIT and the Brigham and Womens Hospital, Harvard University Medical School, Boston, USA, and later held faculty positions at the Pulmonary Center, Boston University, Boston, and University of Maryland Cancer Center, Baltimore, Maryland, USA. Dr. Rishi is currently a professor at the Karmanos Cancer Institute and the Oncology Department of the Wayne State University School of Medicine, Detroit, Michigan, USA.
 

 Biography
Research Interest :

Dr. Rishi’s research interests focus on studying pathways and molecular mechanisms regulating cell growth/survival and death/apoptosis in cancer cells. Dr. Rishi identified and characterized a novel, apoptosis inducing protein termed CARP-1/CCAR1 that regulates apoptosis induced by diverse agents including an apoptogenic retinoid CD437, Adriamycin, Etoposide, but not by chemotherapy agents such as Cisplatin. CARP-1 also regulates apoptosis by EGFRs and protein kinase A. CARP-1 is a phospho-protein that functions in part by interacting with multiple regulators of cell growth and apoptosis signaling. Data from biopsies of human breast cancers and Non-Hodgkin’s Lymphomas (NHL) suggest an inverse correlation of CARP-1 expression with the grades of the tumors, indicating a potential prognostic value and a tumor suppressor property of CARP-1. Our on-going studies are focused to further elucidate the molecular mechanisms of adriamycin and EGFRs signaling that target CARP-1 and CARP-1 interactions with regulators of cell growth and apoptosis. Our long-term goal is to exploit this knowledge for development of strategies to inhibit a variety of cancers including the drug-resistant cancers.
 

 Research Interest
 Network
Fenghuang Zhan

Fenghuang Zhan
Associate Professor
Department of Medicine
University of Utah
USA
 

Biography :

Dr.Fenghuang Zhan, MD, PhD, is an associate professor in the Utah Myeloma Program at the University of Utah (UU), and an investigator at Huntsman Cancer Institute. Zhan is a graduate of West China Medical University (DDS) and Hunan Medical University in Changsha (MD), China, where he earned a masters degree in oral pathology and maxillofacial surgery and a PhD in cancer molecular genetics. He completed postdoctoral fellowships at the University of Louisville in Kentucky and the University of Arkansas for Medical Sciences in Little Rock.
Prior to joining UU, Zhan was an assistant professor at the Myeloma Institute for Research and Therapy at the University of Arkansas for Medical Sciences.
Zhan is a leader in the field of myeloma research. His area of study includes seeking to define genes that make some myeloma cells resistant to chemotherapy. He also studies gene functions and cancer therapeutics using mouse and zebrafish models.

 Biography
Research Interest :

Myeloma stem cell and drug resistance, New targets for myeloma therapy.

 Research Interest
 Network
Lisa M. Hodge

Lisa M. Hodge
Associate Professor
Department of Molecular Biology and Immunology
University of North Texas Health Science Center
USA

Biography :

Dr. Lisa M. Hodge is an Associate Professor in the Department of Molecular Biology and Immunology and holds a joint appointment with the Osteopathic Research Center at the University of North Texas Health Science Center at Fort Worth, Texas. In addition, Dr. Hodge is the Basic Science Research Chair for the National Osteopathic Heritage and is a member of the Louisa Burns Osteopathic Research Committee.The long-range research goal of her laboratory is to evaluate the effect of alternative medicine treatments on the lymphatic and immune systems during infection, inflammation and cancer. Understanding the mechanisms by which these treatments augment the lymphatic and immune systems will provide scientific support for their clinical use.Her research is funded by the National Institutes of Health the American Osteopathic Association and the Osteopathic Heritage Foundation

 Biography
Research Interest :

The long-range research goal of my laboratory is to evaluate the effect of alternative medicine treatments on the lymphatic and immune systems during infection, inflammation and cancer. We have shownthat treatments designed to enhance lymphatic flow (lymphatic pump treatments)increase the numbers of immune cells and mucosal derived lymphocytes in lymphatic circulation. Additionally, we have shown these treatments reduce pulmonary bacteriain rats with pneumonia and inhibit the formation of tumors in the lungs of rats with cancer. It is likely that by enhancing the lymphatic redistribution of lymphocytes, these treatmentsfacilitate the pulmonary trafficking of immune cells with protective biological activities; however, the exact mechanism is still under investigation.  The results obtained from these studies will provide an evidence base for the use or contraindication of certain forms of alternative medicine in patients with infection, inflammatory disease or cancer. This research is supported by the National Institutes of Health (NIH: U19 AT002023, R01 AT004361) and the American Osteopathic Association
 

 Research Interest
 Network
Sinisa Dovat

Sinisa Dovat
Associate Professor
Division of Pediatric Hematology/Oncology
Pennsylvania State University
USA
 

Biography :

Dr. Dovat completed his clinical training in Pediatrics in Penn State University, and in Pediatric Hematology/Oncology at UCLA-Children’s Hospital. He received his research training at Cornell University Graduate School of Medical Sciences and at Howard Hughes Medical Institute at UCLA. During his postdoctoral training at UCLA, Dr. Dovat began his research on the role of Ikaros family genes in normal hematopoiesis and in leukemia. As an independent investigator at the University of Wisconsin, Dr. Dovat focused his work on the regulation of the tumor suppressor activity of Ikaros in childhood leukemia. Results of his research led to the discovery that CK2 kinase negatively regulates the tumor suppressor activity of Ikaros in leukemia and identified three signal transduction pathways that control Ikaros function: CK2 kinase, Protein Phosphatase 1 (PP1), and ubiquitination, These data provided a mechanistic basis for the use of CK2 inhibitors for treatment of hematological malignancies. Dr. Dovat is the recipient of The Young Investigator Award by The American Society of Pediatric Hematology/Oncology, and has been included in the Best Doctors in America list since 2008. His research is supported by a National Institute of Health (NIH) R01 grant and the St. Baldrick’s Foundation. Dr. Dovat accepted the position of Four Diamond Endowed Chair and Director of Translational Research and Experimental Therapeutics in Pediatric Hematology/Oncology at Penn State Universitybeginning in September, 2010, Concurrently, Dr. Dovat is studying epigenomic regulation of cellular immortalization and senescence in leukemia.

 Biography
Research Interest :

Signal transduction regulation of chromatin remodeling in leukemia Transcriptional Regulation in Hematopoiesis and Leukemia
Zinc finger genes in immune response and T and B cell development
Role of Ikaros in tumor suppression of leukemia/lymphoma
Epigenetic regulation of cellular proliferation

 Research Interest
 Network
Igor M. Belyakov

Igor M. Belyakov
Department of Internal Medicine
Nanotechnology Institute for Medicine and Biological Sciences
University of Michigan Medical School
USA

Biography :

After receiving his M.D. with honour from the Vladikavkazs Medical Institute, Russia, in 1983, Igor Belyakov obtained his Ph.D. in Immunology from the the Chelyabinsk Medical School, Russia. In 1993, he received his Sc.D. degree (in immunology and medicine) from the Institute of Immunology, Moscow, Russia, on the basis of research on the effect of Chernobyl radiation on the human immune system. In 1993, he started a postdoctoral fellowship at the University of Alabama at Birmingham, Alabama, and then joined the Molecular Immunogenetics and Vaccine Section of the National Cancer Institute in 1996. Currently Dr. Belyakov is a faculty member in the Department of Internal Medicine in the University of Michigan, School of Medicine. He is a member (Academician) of Russian Academy of Natural Sciences (2009) and member of the American Association of Immunologist (1999). He received the USSR Society of Radiobiology Honor Award in 1992, Fellow Award for Research Excellence (FARE Award) in 2002, National Institute of Health, Fellowship Advancement Award, Division of Clinical Sciences, National Cancer Institute, NIH in 2000. A major focus of his research has been cytotoxic T lymphocytes, mucosal immunity and mucosal vaccines, especially for HIV.

 Biography
Research Interest :

Dr.Belyako area of expertise is in mucosal immunology, basic mechanisms of inflammation, animal models of infection and tumors, viral immunology, pathogen-associated cancers, the immunology of host-pathogen interactions, and development of vaccines against chronic infectious diseases and cancer. He has made significant contributions to elucidating new fundamental principles governing T cell activation, regulation, and effector function. He uses these new fundamental principles to develop more effective mucosal vaccines and immunotherapy strategies for pathogens causing infectious diseases in human and animals (including HIV-1, SIV, Poxvirus, RSV, and others). Highlights of Dr.Belyakov research include demonstration that mucosal immunization with a synthetic, multideterminant HIV peptide construct plus cholera toxin adjuvant induced long-lasting, antigen-specific memory in both the inductive (Peyers patch) and effector (lamina propria) mucosal sites, as well as in systemic sites (Belyakov et al. Proc. Natl. Acad.Sci., Vol.95, pp1709-1714, 1998). He presented the first direct demonstration of the importance of mucosal cytotoxic T lymphocytes in protection against mucosal transmission of virus (Belyakov et al. J. Clin. Invest. 1998. Vol.102, pp2072-2081). Mucosal viral transmission was dependent on CD8+ CTL that had to be present in the mucosal site to be effective and systemic CTL were not sufficient. This result has important implications for vaccine development, in that if a vaccine is going to protect against mucosal transmission of virus, it will likely have to induce specific CTL at the mucosal sites of exposure, and not just in the systemic circulation. He also demonstrated that the choice of mucosal adjuvant affects the cytokine enviroment, and the mucosal response and protection can be enhanced by manipulating the cytokine environment with synergistic cytokine combinations incorporated in the vaccine

 Research Interest
 Network
Mojtaba Akhtari

Mojtaba Akhtari
Department of Oncology and Hematology
University of Nebraska Medical Center
USA
Read Interview session with Mojtaba Akhtari

Biography :

Dr. Mojtaba Akhtari is an Assistant Professor in the Department of Internal Medicine, Division of Hematology and Oncology at the University of Nebraska Medical Center (UNMC). He earned his medical degree from Tehran University of Medical Sciences in Tehran, Iran. Then, he moved to England, where he received training in internal medicine and hematology. He served in the Department of Hematological Medicine, Kings College Hospital in London, England. He moved to Evanston, Illinois, USA, where he completed his residency in internal medicine at Saint Francis Hospital of Evanston, and he also received Humanism in Medicine Award. He undertook fellowship training in hematology and medical oncology at Winship Cancer Institute, Emory University School of Medicine in Atlanta, Georgia, and during this time he specialized in the management of benign and malignant hematological disorders and stem cell transplantation. He is an active member of the American Society of Hematology (ASH) and American Society for Blood and Marrow Transplantation (ASBMT). Dr. Akhtari is a member of the Chronic Myeloid Leukemia Panel of the National Comprehensive Cancer Network (NCCN)

 Biography
Research Interest :

Acute and chronic leukemias as well as myelodysplastic syndromes, therapy-related myeloid neoplasms, familial leukemias and lymphomas, immune cytopenias, and bone marrow transplantation.

 Research Interest
 Network
Ekaterina Ivanovna Galanzha

Ekaterina Ivanovna Galanzha
Department of Otolaryngology
University of Arkansas for Medical Sciences
USA
 

Biography :

Ekaterina Galanzha is the leading scientists in the Philips Classic Laser & Nanomedicine Laboratories and an Assistant Professor at the University of Arkansas for Medical Sciences, USA. She received her MD, PhD and DSc degrees from Saratov Universities, Russia. Dr. Galanzha is the co-author of 3 books and more than 50 papers. Her interdisciplinary expertise includes nanomedicine, cell biology, experimental medicine, biophotonics with a focus on blood and lymph circulation. She is a co-inventor of the in vivo multicolor photoacoustic blood and lymph flow cytometry.

 Biography
Research Interest :

Physiology and pathology of lymph circulation and lymph nodes
Cancer research, metastasis, circulating tumor cells, cancer stem cells
Blood and lymph rheology, clot formation, cell aggregation
Nanomedicine
In vivo flow cytometry
Photoacoustics
 

 Research Interest
 Network
Farrukh Tauseef Awan

Farrukh Tauseef Awan
Department of Internal Medicine
Section of Hematology/Oncology
Georgia Health Science University
USA
 

Biography :

Dr.Farrukh T Awan obtained his M.S. in clinical Research at Center of Research on Health Care and Graduate School of Public Health, University of Pittsburgh. His postdoctoral training was at The Ohio State University. He is appointed as Ass. Professor at Georgia Health Science University in Department of Internal Medicine, Medical College of Georgia, Section of Hematology/Oncology.

 Biography
Research Interest :

Novel therapies for B-cell malignancies especially chronic lymphocytic leukemia and non-Hodgkin’s lymphoma

 Research Interest
 Network
Yu Chen

Yu Chen
Division Head
Department of Laboratory Medicine
Dr. Everett Chalmers Regional Hospital
Canada
 

Biography :

Dr.Yu Chen has received his MD at Central South University of China and finished PhD at Dalhousie University, Halifax, Nova Scotia, Canada in 2005 . Currently, he is working as certified Clinical Biochemist and Division Head of Clinical Biochemistry in Horizon Health Network, New Brunswick, Canada. He /she is serving as an editorial member of several reputed journals like Inflammation Allergy Drug Target, Journal of Bioscience and Medicine, and as frequent reviewer for 7 journals. He /she has authored over 20 research articles/books. He/she is a member of Canadian Society of Clinical Chemists (CSCC), and American Association of Clinical Chemists (AACC), and he is a fellow of National Academy of Clinical Biochemistry (NACB), and Canadian Academy of Clinical Biochemistry. He/she has honored as Killiam scholar won numerous awards from AACC.

 Biography
Research Interest :

Cardiovascular diseases; Disease-specific biomarkers; serum protein electrophoresis, Clinical Biochemistry

 Research Interest
 Network
Ionel Alexandru Checherita

Ionel Alexandru Checherita
Department of Nephrology, Urology and Transplant Immunology
Carol Davila University of Medicine
Romania
 

Biography :

I am Associated Professor at the Department of Nephrology, Urology, Transplant Immunology, Dermatology and Alergology, “Carol Davila” University of Medicine and Pharmacy Bucharest, Romania. In addition, I am Medical Head of the Department of Nephrology and Dialysis, “St. John” Emergency Clinical Hospital, Bucharest, Romania. Since my beginning as nephrology doctor, I participated to different national and international congresses and symposiums, and each year, I tried to gain more medical knowledge by attending to prestigious academic courses. Because of my constant interest of patients’ quality of life, together with colleagues from my Department, I developed a new renal replacement therapy method, a concept that was warmly appreciated by international and national nephrology community. I am an active member in various national and international journals’ editorial board and medical associations (ISN and ERA-EDTA), because I believe only working together and sharing information we could contribute to medical progress. As a proof of my constant work as doctor and researcher, I published many articles regarding renal pathology, potential life-threatening complications and new treatment concepts for improving patients outcome. In the future, I hope my academic career and research will better and I would be able to improve Romanian medical system and discover new therapy techniques for slowing chronic kidney disease natural evolution.

 Biography
Research Interest :

Renal pathology and physiology, nephropaties caused by renal or extrarenal diseases, acute renal failure, chronic kidney disease, cardiovascular and hematological complications in renal patients, interventional nephrology, treatment options, dialysis and renal transplantation.

 Research Interest
 Network
Hamoud Al-Mousa

Hamoud Al-Mousa
Department of Pediatric Allergy & Immunology
King Faisal Specialist Hospital & Research Center
Saudia Arabia
 

Biography :

Dr. Hamoud Al-Mousa is a Consultant and Head section of Pediatric Allergy and Immunology at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudia Arabia, associate professor of Pediatrics at Al-Faisal University and holds a joint appointment as a scientist at the immune genetic laboratory in research centre. He received his MD from King Saud university and finished his pediatric residency and fellowship training at King Faisal Specialist Hospital and Research Centre then he spend a two years training at the pediatric immunology and hematology unit at Necker-Enfants malades Paris, France. Dr Al-Mousa major research interests are primary immunodeficiency disorders and stem cell transplantation. His research is directed to identify the underlying genetic defects of primary immunodeficiency disorders in the region.

 Biography
Research Interest :

Primary immunodeficiency disorders (PIDs) Stem cell transplantation for PIDs Genetics of immunological disorders

 Research Interest
 Network
Nwabo Kamdje Armel Herve

Nwabo Kamdje Armel Herve
Department of Biomedical Sciences
University of Ngaoundere
Cameroon

Biography :

  Nwabo Kamdje, MSc, PhD, is an assistant professor at the Department of
Biomedical Sciences at the University of Ngaoundere-Cameroon. He has a
master degree in Biochemistry and a PhD in Human Oncological Pathology
and Stem Cell and Clinical Application. He currently works on the
following topics:

1- Epigenetic regulation in normal hematopoiesis and in hematological
malignancies

2- Role of Notch signalling in leukaemia

3- Signalling pathways in hematological malignancies within the bone
marrow microenvironment.

 Biography
Research Interest :

 His research interest are Hematological malignancies, Signaling pathways, Bone marrow microenvironment, Epigenetics, Inflammation, Blood cancers and others

 Research Interest
 Network
Ti Zhang

Ti Zhang,
Department of Pharmaceutical Chemistry
University of Kansas
USA

Biography :

 Ti Zhang obtained her PhD in Pharmaceutics and Drug Delivery at the Department of Pharmaceutical Chemistry of the University of Kansas. She got her BS in Chemistry from Nankai University (Tianjin, China) in 2006, followed by a MS in Analytical Chemistry in 2008 at Wuhan University (Hubei, China). Her research interests include the development of tumor-targeted contrast agent for photoacoustic imaging as well as polymeric nanocarriers that allow anti-cancer agents delivery in a controlled manner to the tumors and treatment specifically in response to the external energy.

 Biography
Research Interest :

Development of tumor-targeted contrast agent for photoacoustic imaging as well as polymeric nanocarriers that allow anti-cancer agents delivery in a controlled manner to the tumors and treatment specifically in response to the external energy.

 Research Interest
 Network
Persio Roxio

Persio Roxo
Professor of Pediatric Allergy & Immunology
Department of Pediatrics, Ribeirão Preto Medical School
University of São Paulo 
Brazil.

Biography :

1983-1988 Graduated in Medical Sciences, Ribeirão Preto Medical School, University of São Paulo, Brazil.
1989-1991 Medical Residence in Pediatrics, Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Brazil
1991-1994 Master Thesis in Pediatrics, Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Brazil.
1995-1999 PhD in Pediatrics, Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Brazil.
2004-2004 Clinical Fellowship, State University Health Sciences Center, New Orleans (USA).
2005-2005 Clinical Fellowship, University of Newcastle upon Tyne (UK).

 Biography
Research Interest :

Primary immunodeficiency diseases
Molecular diagnoses of primary immunodeficiency.
Ontogeny of innate immune response.

 Research Interest
 Network
Preethi Ravindranathan


 Preethi Ravindranathan
 Research Associate
 UT Southwestern Medical Center,
 Dallas,USA

Biography :

Research Associate May 2014-Present UT Southwestern Medical Center, Dallas TX
Research Technician II Jun 2014-May 2014 UT Dallas, Dallas, TX (Site of activity: UT Southwestern Medical Center, Dallas TX)
Research Technician II Dec 2008-Apr 2011 UT Southwestern Medical Center, Dallas TX
Graduate Research Assistant Aug 2006-Oct 2008 UT Health Science Center at Tyler, Tyler TX

 Biography
Research Interest :

Prostate cancer
Small molecule drugs
Peptidomimetics
Androgen Receptor
Breast cancer
Molecular endocrinology

 Research Interest
 Network
Mohamed Amine Bekadja

Mohamed Amine Bekadja
Head of Department  
Faculty of Medicine

algiers university aligiers

Biography :

Titles Academic Year Institution :

Doctor of Medicine in 1978
Faculty of Medicine Oran Docent 1994
Faculty of Medicine of Algiers Professor Faculty of Medicine of Algiers 1999 Head of Department ,
Faculty of Medicine in 2004
Algiers Professional background :
Stage training Course St Louis Hospital Paris (Prof. JM Andrieu : 1982)
Stage training Hospital Malmo Sweden (Pr S Cronberg : 1989)
Stage training Course Hotel Dieu Hospital Paris (Prof. R.Zittoun : 1992) Responsibilities performed : President of the Algerian Society of Hematology and Blood Transfusion (2009-2013)
National Coordinator of Algerian Study Group AML and myelodysplasia Developed areas in public health: Open Unit autograft in May 2009
Open allograft Unit in April 2012 -Member of the EBMT (since 2010,
CIC No. 993) -Member of the EMBMT (since 2011) -Member of the Francophone Group of myelodysplasia (since 2010) -Member of the Reading Committee (Editorial Board) to "Hematology-oncology and stem cell therapy" (since 2011)

 Biography
Research Interest :

Hematology and Cell Therapy
Onco - Hematology 
autograft  
allograft
CSP

 Research Interest
 Network
Mohammad Mahdi Sarzaeem

Mohammad Mahdi sarzaeem
Assistant Professor,
Department of Orthopeadic Surgery
Shahid Beheshti University of Medical sciences
(Tehran -Iran)

Biography :

He has received his certificate in orthopedic surgery in Tehran university during 2001-2005,
He is specialized of adult reconstructive surgery both in knee and hip,also in sports medicine
 Assistant professor of orthopedic department in Imam Hossein Hospital Tehran since 2007,

 Biography
Research Interest :

Complication in total joint replacement
Blood conversation in joint replacement
Thromboembolic events prevention
Primary Joint replacement both hip and knee

 Research Interest
 Network
Dongsheng Xu
Medical Director
Hematopathology & Flow Cytometry Laboratory
CBLPath, Inc
760 Westchester Avenue
Rye Brook, NY, USA
Biography :
 Biography
Research Interest :

My research interests include clinical application of cell population data, leukemia/lymphoma immunophenotyping by flow cytometry and molecular diagnosis of hematolymphoid neoplasm.

 Research Interest
 Network
Guldeep Uppal
Assistant Professor
Division of Hematopathology
Philadelphia, PA, USA
Biography :

 I am a working as an assistant professor in the division of hematopathology in the Department of Pathology at Thomas Jefferson University Hospital, Philadelphia. I obtained my hematopathology fellowship at Thomas Jefferson University Hospital, Philadelphia. I am board certified in AP/CP as well as hematopathology. I did my pathology residency training at Temple University Hospital, Philadelphia. 

I underwent my medical education in India including a residency in pathology. Soon after my residency, I joined St George’s Medical School, Grenada, West Indies, as an assistant professor in the department of pathology where I worked for 3 years.

 Biography
Research Interest :

My research interests include CNS lymphomas, immunodeficiency associated lymphoproliferative disorders, therapy associated neoplasms and acute myeloid leukemia.

 Research Interest
 Network
Sergey V. Sennikov

Sergey V. Sennikov

Head

Research Institute of Fundamental and Clinical Immunology

Novosibirsk
Russia

Biography :

In 1984 S.V. Sennikov graduated from Siberian State Medical University (Tomsk) with specialty biochemistry. From 1984 to 1987 he was studying for his Ph.D. at the Federal State Budgetary Scientific Institution “Research Institute of Fundamental and Clinical Immunology”, Novosibirsk and in 1988 he received PhD degree in Medical sciences on Allergology and Immunology speciality with thesis “Influence of erythroblasts on reactions of humoral and cell mediated immunity”. From 1988 to present time he worked in. Federal State Budgetary Scientific Institution “Research Institute of Fundamental and Clinical Immunology”; since 2004 – in in capacity of head of the laboratory of molecular immunology and deputy director for scientific efforts. In 2002 he received his GrandPhD degree in Medical sciences with thesis “Cytokine synthesizing activity of erythroid nucleated cells”. In 2005 he was promoted to the rank of professor in Allergology and Immunology speciality.

 Biography
Research Interest :

cellular and molecular immunology, cytokines.

 Research Interest
 Network
 Acceptance Letter
Pérsio Roxo-Junior Pérsio Roxo-Junior


Professor of Pediatric Allergy & Immunology
Department of Pediatrics
Ribeirão Preto Medical School

University of São Paulo


Brazil.

Biography :
 Biography
Research Interest :

Primary immunodeficiency diseases.
Molecular diagnoses of primary immunodeficiency.
Ontogeny of innate immune response.

 Research Interest
 Network
 Acceptance Letter
 
 
 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version